Package Leaflet: Information for the User
DulcoLax Bisacodyl 10 mg Suppositories
Bisacodyl
Read the entire package leaflet carefully before starting to use this medication, as it contains important information for you.
Follow the administration instructions for the medication contained in this package leaflet or as indicated by your doctor or pharmacist.
Package Leaflet Contents:
The bisacodyl, the active ingredient of this medication, belongs to the group of stimulant laxatives, which act by direct contact with the intestinal mucosa, stimulating the nerve endings of the intestinal wall, thereby increasing its motility.
It is indicated for the symptomatic relief of occasional constipation in adults, adolescents, and children over 10 years old.
You should consult a doctor if your symptoms worsen or if you do not improve after 7 days of treatment.
Do not use DulcoLax:
Warnings and Precautions
Consult your doctor or pharmacist before starting to use DulcoLax:
Children and Adolescents
Children under 10 years old cannot use this medication.
Using DulcoLax with other medications
Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.
In particular, if you are using any of the following medications, it may be necessary to interrupt treatment or modify the dose of one of them:
Interference with diagnostic tests:
Using DulcoLax with food and drinks
You should not take licorice while using this medication.
Pregnancy, Breastfeeding, and Fertility
If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medication.
Driving and Using Machines
During the use of this type of laxative, due to a vasovagal response (e.g., abdominal spasms), you may experience dizziness and/or fainting. If you experience abdominal spasms, you should avoid potentially hazardous tasks such as driving or operating machinery.
Follow the administration instructions for this medication contained in this package leaflet or as indicated by your doctor or pharmacist. In case of doubt, consult your doctor or pharmacist again.
The recommended dose in adults is:
1 suppository (10 mg of bisacodyl).
This medication is administered rectally.
They should be unwrapped and inserted into the rectum by the pointed end.
The effect usually appears 20 minutes after administration (between 10 and 30 minutes).
If your symptoms worsen, if you do not have a bowel movement after 12 hours, or if your symptoms persist after 7 days of treatment, you should consult a doctor.
Use in Children and Adolescents
Adolescents and children over 10 years old.
The recommended dose is 1 suppository (10 mg of bisacodyl).
Children under 10 years old cannot use this medication, as it contains 10 mg of bisacodyl.
If you use more DulcoLax than you should
If you have used more DulcoLax than you should, consult your doctor or pharmacist immediately.
The most frequent symptoms of overdose are: abdominal cramps, vomiting, mucous and diarrheic stools, and loss of fluid, potassium, and other electrolytes, fatigue or weakness.
Treatment in these cases will consist of discontinuing the use of the laxative and subsequent rehydration with saline solution, fluids, and administration of mineral salts. These measures are especially important in the elderly and young.
In case of overdose or accidental ingestion, consult your doctor or call the Toxicology Information Service (telephone: 91 562 04 20), indicating the medication and the amount ingested.
Like all medications, this medication can cause side effects, although not everyone will experience them.
During the period of use of medications with bisacodyl, the following side effects have been observed, whose frequency could not be established with precision. The most frequent side effects are abdominal pain and diarrhea. It can also cause: abdominal discomfort, anorectal discomfort, digestive disorders such as abdominal pain or cramps (which can be associated with nausea and/or vomiting), bloody stools (hematochezia), flatulence, abdominal distension, increased slowness of intestinal movement, and colitis. Less frequently, allergic reactions, skin rashes, dehydration, and swelling of the face, lips, mouth, tongue, or throat that can cause difficulty swallowing or breathing (angioedema) can also occur.
The use of medications with bisacodyl, the active ingredient of this medication, for long periods of time, can cause increased loss of water, potassium, and other salts. This can lead to alterations in cardiac function, muscle weakness, and fatigue, particularly if administered simultaneously with diuretic and corticosteroid medications.
Additionally, cases of dizziness and fainting have been reported. The dizziness and fainting that appear after taking medications with bisacodyl may be due to a vasovagal response (e.g., abdominal spasm, defecation).
Reporting of side effects:
If you experience any type of side effect, consult your doctor or pharmacist, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Medication Surveillance System for Human Use: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.
Keep this medication out of the sight and reach of children.
Do not store above 30°C.
Expiration Date
Do not use this medication after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.
Medications should not be disposed of through wastewater or household waste. Deposit the packaging and medications you no longer need at the SIGRE point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medications you no longer need. This will help protect the environment.
DulcoLax Composition
Product Appearance and Package Contents
DulcoLax are white-yellowish suppositories.
They come in packages containing an aluminum blister pack of 6 or 12 suppositories.
Marketing Authorization Holder:
Opella Healthcare Spain, S.L.
C/Rosselló i Porcel, 21
08016 – Barcelona
Spain
Sanofi Group
Manufacturer:
Istituto de Angeli, S.r.l.
Località Prulli, 103/C
50066 Reggello (Florence).
Italy
Date of the Last Revision of this Package Leaflet:October 2019
Detailed and updated information on this medication is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.